class="p1">Michael B. First et al., “Clinical Applications of Neuroimaging in Psychiatric Disorders,” American Journal of Psychiatry 175, no. 9 (September 1, 2018): 915-16.

67

Max Planck, Scientific Autobiography and Other Papers (New York: Philosophical Library, 1949), 33–34.

68

Подробную информацию обо всех книгах автора можно найти в начале книги.

69

Fred A. Mettler Jr. et al., “Radiologic and Nuclear Medicine Studies in the United States and Worldwide: Frequency, Radiation Dose, and Comparison with Other Radiation Sources – 1950–2007,” Radiology 253, no. 2 (November 2009): 520-31.

70

Michael D. Devous et al., “Single-Photon Emission Computed Tomography in Neurotherapeutics,” NeuroRx 2, no. 2 (April 2005): 237-49.

71

Ronald Jack Jaszczak, “The Early Years of Single Photon Emission Computed Tomography (SPECT): An Anthology of Selected Reminiscences,” Physics in Medicine & Biology 51, no. 13 (July 7, 2006): R99-115.

72

“Brain SPECT,” Cedars-Sinai (2019), www.cedars-sinai.edu/Patients/Programs-and-Services/Imaging-Center/For-Patients/Exams-by-Procedure/Nuclear-Medicine/Brain-SPECT.aspx; Mayo Clinic staff, “SPECT Scan,” Mayo Clinic (December 23, 2016), www.mayoclinic.org/tests-procedures/spect-scan/about/pac-20384925.

73

S. Yassin et al., “Differences in SPECT Perfusion in Children and Adolescents with ADHD,” Archives of Clinical Neuropsychology 29, no. 6 (September 2014): 541-42 Daniel G. Amen and B. D. Carmichael, “High-Resolution Brain SPECT Imaging in Attention Deficit Hyperactivity Disorder,” Annals of Clinical Psychiatry 9, no. 2 (June 1997): 81–86.

74

Daniel G. Amen et al., “Predicting Positive and Negative Treatment Responses to Stimulants with Brain SPECT Imaging,” Journal of Psychoactive Drugs 40, no. 2 (June 2008): 131-38.

75

Daniel G. Amen et al., “Patterns of Regional Cerebral Blood Flow as a Function of Age throughout the Lifespan,” Journal of Alzheimer’s Disease 65, no. 4 (September 25, 2018): 1087-92.

76

J. Link et al., “SPECT Differences between Those with Higher and Lower Levels of Aggression: An Exploratory Analysis,” Archives of Clinical Neuropsychology 29, no. 6 (September 2014): 576.

77

Daniel G. Amen et al., “An Analysis of Regional Cerebral Blood Flow in Impulsive Murderers Using Single Photon Emission Computed Tomography,” Journal of Neuropsychiatry and Clinical Neuroscience 19, no. 3 (Summer 2007): 304-9.

78

Jada J. Stewart et al., “Diagnostic Accuracy of SPECT Scans: Examining Specific Brain Areas of Regional Hypoperfusion at Baseline in Alzheimer’s Disease,” Archives of Clinical Neuropsychology (2014).

79

J. Messerly et al., “Preliminary Investigation of SPECT Differences between Individuals with Varying Levels of Anxiety,” Archives of Clinical Neuropsychology 29, no. 6 (September 2014): 579.

80

Daniel G. Amen et al., “Functional Neuroimaging Distinguishes Autistic Spectrum Disorder from Healthy and Comorbid Conditions in Focused and Large Community Datasets,” Journal of Systems and Integrative Neuroscience 3 (April 2017).

81

Daniel G. Amen et al., “Deficits in Regional Cerebral Blood Flow on Brain SPECT Predict Treatment Resistant Depression,” Journal of Alzheimer’s Disease 63, no. 2 (2018): 529-38.

82

Lucas Driskell et al., “A SPECT Exploratory Analysis of Differentiating Mania Symptomology Severity,” Archives of Clinical Neuropsychology 29, no. 6 (September 2014): 578.

83

Daniel G. Amen et al., “Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging,” Journal of Alzheimer’s Disease 57, no. 1 (2017): 253-66.

84

Daniel G. Amen et al., “Gender-Based Cerebral Perfusion Differences in 46,034 Functional Neuroimaging Scans,” Journal of Alzheimer’s Disease 60, no. 2 (2017): 605-14.

85

Daniel G. Amen et al., “Functional Neuroimaging Distinguishes Posttraumatic Stress Disorder from Traumatic Brain Injury in Focused and Large Community Datasets,” PLOS One (July 1, 2015), http://journals.plos.org/plosone/article?id=10.1371/journal. pone.0129659. Cyrus A. Raji et al., “Functional Neuroimaging with Default Mode Network Regions Distinguishes PTSD from TBI in a Military Veteran Population,” Brain Imaging and Behavior 9, no. 3 (September 2015): 527-34.

86

Daniel G. Amen et al., “Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer’s Dementia,” Journal of Alzheimer’s Disease 56, no. 1 (2017): 261-73.

87

Andrew B. Newberg et al., “Cerebral Blood Flow Differences between Long-Term Meditators and Non-Meditators,” Consciousness and Cognition 19, no. 4 (December 2010): 899–905. Dharma Khalsa et al., “Cerebral Blood Flow Changes during Chanting Meditation,” Nuclear Medicine Communications 30, no. 12 (December 2009): 956-61.

88

Daniel G. Amen et al., “Quantitative Erythrocyte Omega-3 EPA Plus DHA Levels Are Related to Higher Regional Cerebral Blood Flow on Brain SPECT,” Journal of Alzheimer’s Disease 58, no. 4 (2017): 1189-99.

89

K. Willeumier et al., “Elevated Body Mass in National Football League Players Linked to Cognitive Impairment and Decreased Prefrontal Cortex and Temporal Pole Activity,” Translational Psychiatry 2, no. 1 (January 2012): e68. K. Willeumier et al., “Elevated BMI Is Associated with Decreased Blood Flow in the Prefrontal Cortex Using SPECT Imaging in Healthy Adults,” Obesity 19, no. 5 (May 2011): 1095-97.

90

K. Willeumier et al., “Decreased Cerebral Blood Flow in the Limbic and Prefrontal Cortex Using SPECT Imaging in a Cohort of Completed Suicides,” Translational Psychiatry 1, no. 8 (August 9, 2011): e28. Daniel G. Amen et al., “A Comparative Analysis of Completed Suicide Using High Resolution Brain SPECT Imaging,” Journal of Neuropsychiatry and Clinical Neurosciences 21, no. 4 (Fall 2009): 430-39.

91

Cyrus A. Raji et al., “Clinical Utility of SPECT Neuroimaging in the Diagnosis and Treatment of Traumatic Brain Injury: A Systematic Review,” PLOS One 9, no. 3 (March 19, 2014): e91088.